3,5-Dihydroxybenzoic Acid (3,5-DHBA), identified by CAS 99-10-5, is more than just a chemical compound; it's a subject of growing interest in the study of organic acid metabolism and its intricate connection with the human gut microbiome. This hydroxybenzoic acid derivative is endogenously produced in the gastrointestinal tract through the microbial breakdown of specific dietary components, particularly those rich in polyphenols.

Research has illuminated 3,5-DHBA's role as a metabolite of alkylresorcinols, naturally occurring compounds found in whole grains. Its presence in urine and plasma serves as a potential biomarker for whole-grain intake and also offers insights into gut microbial activity. Elevated levels can sometimes indicate dysbiosis, a condition characterized by an imbalance in the gut microbial community. Understanding these metabolic pathways is crucial for functional medicine practitioners seeking to assess gut health and overall metabolic function.

Furthermore, 3,5-DHBA has demonstrated a specific action as an agonist for the hydroxycarboxylic acid receptor 1 (HCA1), showing potential in inhibiting lipolysis and aiding in metabolic regulation, particularly for dyslipidemia. This dual role—as a dietary indicator and a metabolically active compound—makes it a valuable subject for scientific inquiry. For researchers and clinicians interested in studying organic acid profiles and gut health, sourcing high-quality 3,5-Dihydroxybenzoic Acid from reputable manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. is essential. Exploring the price and procurement of this compound supports advancements in personalized health and metabolic research.